Rapid-dissolution mitiglinide preparation, and preparation method and detection method thereof

A technology for mitiglinide calcium and preparations, which is applied to rapidly dissolving mitiglinide calcium preparations and the fields of preparation and testing thereof, can solve the problems of affecting patient confidence, high failure rate, weight gain, etc., and avoid granulation time. And the mixing speed is too low, it is not easy to generate dust, and the properties are uniform.

Active Publication Date: 2016-05-11
YICHANG HEC CHANGJIANG PHARMA CO LTD
View PDF1 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Among them, in addition to the high failure rate of the first treatment of sulfonylureas, about 10% of patients do not respond to subsequent treatments, and their main adverse reactions are hypoglycemia and severe weight gain; although biguanides were introduced in the 1950s It has not been used in the treatment of diabetes, but the obvi

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Rapid-dissolution mitiglinide preparation, and preparation method and detection method thereof
  • Rapid-dissolution mitiglinide preparation, and preparation method and detection method thereof
  • Rapid-dissolution mitiglinide preparation, and preparation method and detection method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] Embodiment 1 A kind of mitiglinide calcium tablet of rapid dissolution

[0032] 5 parts of mitiglinide calcium; 40 parts of lactose; 30 parts of microcrystalline cellulose; 20 parts of starch; 55 parts of hypromellose E; 5 parts of carboxymethyl starch; 0.1 part of magnesium stearate.

[0033] The particle size of the mitiglinide calcium bulk drug D(0.5)≤10 μm, D(0.9)≤40 μm.

[0034] Prepare the method for the described mitiglinide calcium preparation of right, described method comprises the following steps:

[0035] 1) Miglinide calcium and lactose were mixed for 10 minutes to obtain material 1;

[0036] 2) Material 1 was put into a wet mixing granulator together with lactose, microcrystalline cellulose, starch, and 30% sodium carboxymethyl starch, and mixed at a stirring speed of 120 rpm / min for 8 minutes to obtain material 2;

[0037] 3) Prepare hypromellose E3 or E5 into an aqueous solution with a concentration of 1%-10%, add material 2 to it, and granulate to obt...

Embodiment 2

[0042] Embodiment 2 A kind of rapidly dissolving mitiglinide calcium capsule

[0043] A mitiglinide calcium preparation, characterized in that the preparation comprises the following components in parts by weight:

[0044] 5 parts of mitiglinide calcium; 30 parts of lactose; 20 parts of microcrystalline cellulose; 30 parts of starch; 1.5 parts of sodium carboxymethyl starch; 32 parts of hypromellose E; 4 parts of sodium carboxymethyl starch; 0.1 part of magnesium stearate.

[0045] The particle size of the mitiglinide calcium bulk drug D(0.5)≤10 μm, D(0.9)≤40 μm.

[0046] Prepare the method for the described mitiglinide calcium preparation of right, described method comprises the following steps:

[0047] 1) mitiglinide calcium and lactose were mixed for 5 minutes to obtain material 1;

[0048] 2) Material 1 was put into a wet mixing granulator together with lactose, microcrystalline cellulose, starch, and 40% sodium carboxymethyl starch, and mixed at a stirring speed of 10...

Embodiment 3

[0054] Embodiment 3, different granularity mitiglinide calcium crude drug preparation mitiglinide calcium tablet dissolution rate influence

[0055] Adopt the method of the present invention, other raw material proportioning and method are consistent, compare the impact of different raw material particle sizes on the dissolution rate of mitiglinide calcium tablets, the specific results are shown in Table 1 (slurry method, 50rpm, 900ml, n=6).

[0056] The influence of table 1 different granularity mitiglinide calcium bulk drug preparation mitiglinide calcium tablet dissolution

[0057]

[0058] As can be seen from Table 1, the particle size of the mitiglinide calcium raw material has a significant impact on the dissolution rate of the mitiglinide calcium tablet. The dissolution rate of mitiglinide calcium tablets can reach more than 90% in 10 minutes.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Login to view more

Abstract

The invention relates to the field of medicinal preparations, and relates to a rapid-dissolution mitiglinide preparation, and a preparation method and a detection method thereof. The prescription of the preparation comprises 4-6 parts of a mitiglinide raw medicine, 25-45 parts of lactose, 15-35 parts of microcrystalline cellulose, 15-35 parts of starch, 1.5-5.5 parts of hydroxypropyl methylcellulose E3 or hydroxypropyl methylcellulose E5, 3-10 parts of sodium carboxymethyl starch and 0.05-0.3 parts of magnesium stearate. The rapid-dissolution mitiglinide preparation has the advantages of easy obtaining of auxiliary materials, low cost, simple preparation method, fast in vitro digestion, realization of the 10min dissolution rate of various dissolution media reaching 90% or above, and stable quality.

Description

technical field [0001] The invention relates to the field of pharmaceutical preparations, in particular to a fast-dissolving mitiglinide calcium preparation and a preparation and detection method thereof. Background technique [0002] In recent years, it has been found that the impairment of insulin secretion in the early phase is an important factor in the development of type 2 diabetes. Therefore, drugs that can restore the early secretion of postprandial insulin and reduce postprandial blood sugar have become effective drugs for the treatment of type 2 diabetes. At present, oral drugs clinically used to treat type 2 diabetes mainly include sulfonylureas (SU), biguanides, α-glucosidase inhibitors, thiazolidinedione (TZD) and glinides, etc. Among them, in addition to the high failure rate of the first treatment of sulfonylureas, about 10% of patients do not respond to subsequent treatments, and their main adverse reactions are hypoglycemia and severe weight gain; although b...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/20A61K9/48A61K31/4035A61K47/38A61K47/36A61K47/26A61P3/10G01N30/02
CPCA61K9/2018A61K9/2054A61K9/2059A61K9/4858A61K9/4866A61K31/4035G01N30/02G01N2030/027
Inventor 鲁科明吴春华周威
Owner YICHANG HEC CHANGJIANG PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap